AtriCure, Inc. Announces The Release Of The AtriClip® FLEX

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and Left Atrial Appendage Management (LAAM), today announced the introduction of the AtriClip® FLEX, a new device with a more flexible aluminum shaft that allows surgeons to better maneuver within a patient’s particular anatomy.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC